PURPOSE: The purpose of this study was to assess the prevalence of male infertility and treatment-related risk factors in childhood cancer survivors. METHODS: Within the Childhood Cancer Survivor Study, 1,622 survivors and 274 siblings completed the Male Health Questionnaire. The analysis was restricted to survivors (938/1,622; 57.8 %) and siblings (174/274; 63.5 %) who tried to become pregnant. Relative risks (RR) and 95 % confidence intervals (CI) for the prevalence of self-reported infertility were calculated using generalized linear models for demographic variables and treatment-related factors to account for correlation among survivors and siblings of the same family. All statistical tests were two-sided. RESULTS: Among those who provided self-report data, the prevalence of infertility was 46.0 % in survivors versus 17.5 % in siblings (RR = 2.64, 95 % CI 1.88-3.70, p < 0.001). Of survivors who met the definition for infertility, 37 % had reported at least one pregnancy with a female partner that resulted in a live birth. In a multivariable analysis, risk factors for infertility included an alkylating agent dose (AAD) score ≥3 (RR = 2.13, 95 % CI 1.69-2.68 for AAD ≥3 versus AAD <3), surgical excision of any organ of the genital tract (RR = 1.63, 95 % CI 1.20-2.21), testicular radiation ≥4 Gy (RR = 1.99, 95 % CI 1.52-2.61), and exposure to bleomycin (RR = 1.55, 95 % CI 1.20-2.01). CONCLUSION: Many survivors who experience infertility father their own children, suggesting episodes of both fertility and infertility. This and the novel association of infertility with bleomycin warrant further investigation. IMPLICATIONS FOR CANCER SURVIVORS: Though infertility is common, male survivors reporting infertility often father their own children. Bleomycin may pose some fertility risk.
PURPOSE: The purpose of this study was to assess the prevalence of male infertility and treatment-related risk factors in childhood cancer survivors. METHODS: Within the Childhood Cancer Survivor Study, 1,622 survivors and 274 siblings completed the Male Health Questionnaire. The analysis was restricted to survivors (938/1,622; 57.8 %) and siblings (174/274; 63.5 %) who tried to become pregnant. Relative risks (RR) and 95 % confidence intervals (CI) for the prevalence of self-reported infertility were calculated using generalized linear models for demographic variables and treatment-related factors to account for correlation among survivors and siblings of the same family. All statistical tests were two-sided. RESULTS: Among those who provided self-report data, the prevalence of infertility was 46.0 % in survivors versus 17.5 % in siblings (RR = 2.64, 95 % CI 1.88-3.70, p < 0.001). Of survivors who met the definition for infertility, 37 % had reported at least one pregnancy with a female partner that resulted in a live birth. In a multivariable analysis, risk factors for infertility included an alkylating agent dose (AAD) score ≥3 (RR = 2.13, 95 % CI 1.69-2.68 for AAD ≥3 versus AAD <3), surgical excision of any organ of the genital tract (RR = 1.63, 95 % CI 1.20-2.21), testicular radiation ≥4 Gy (RR = 1.99, 95 % CI 1.52-2.61), and exposure to bleomycin (RR = 1.55, 95 % CI 1.20-2.01). CONCLUSION: Many survivors who experience infertility father their own children, suggesting episodes of both fertility and infertility. This and the novel association of infertility with bleomycin warrant further investigation. IMPLICATIONS FOR CANCER SURVIVORS: Though infertility is common, male survivors reporting infertility often father their own children. Bleomycin may pose some fertility risk.
Authors: Marleen A E van der Kaaij; Natacha Heutte; Nolwenn Le Stang; John M M Raemaekers; Arnold H M Simons; Patrice Carde; Evert M Noordijk; Christophe Fermé; José Thomas; Houchingue Eghbali; Hanneke C Kluin-Nelemans; Michel Henry-Amar Journal: J Clin Oncol Date: 2007-05-21 Impact factor: 44.544
Authors: Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: J Clin Oncol Date: 2009-04-13 Impact factor: 44.544
Authors: Gwendolyn P Quinn; Bradley J Zebrack; Ivana Sehovic; Meghan L Bowman; Susan T Vadaparampil Journal: Cancer Date: 2015-07-14 Impact factor: 6.860
Authors: Jessica S Flynn; Kathryn M Russell; Vicky Lehmann; Lauren A-M Schenck; James L Klosky Journal: Pediatr Blood Cancer Date: 2020-05-26 Impact factor: 3.167
Authors: Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata Journal: J Adolesc Health Date: 2019-01-14 Impact factor: 5.012
Authors: Jordan Gilleland Marchak; Kristy D Seidel; Ann C Mertens; Chad W M Ritenour; Karen Wasilewski-Masker; Wendy M Leisenring; Charles A Sklar; Jennifer S Ford; Kevin R Krull; Marilyn Stovall; Leslie L Robison; Gregory T Armstrong; Lillian R Meacham Journal: Cancer Date: 2018-04-17 Impact factor: 6.860
Authors: Susan T Vadaparampil; Juliette Christie; Meghan Bowman; Ivana Sehovic; Cathy D Meade; Clement K Gwede; Gwendolyn P Quinn Journal: J Contin Educ Nurs Date: 2016-08-01 Impact factor: 1.224
Authors: Eric J Chow; Kayla L Stratton; Wendy M Leisenring; Kevin C Oeffinger; Charles A Sklar; Sarah S Donaldson; Jill P Ginsberg; Lisa B Kenney; Jennifer M Levine; Leslie L Robison; Margarett Shnorhavorian; Marilyn Stovall; Gregory T Armstrong; Daniel M Green Journal: Lancet Oncol Date: 2016-03-22 Impact factor: 41.316